Vivos Therapeutics, Inc.
VVOS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001716166
No open-market purchases or sales by Vivos Therapeutics, Inc. insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $242.7K in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Vivos Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- −10 vs. Q3 2023
- Shares held
- 257.0K
- −4.22M (−94.3%) vs. Q3 2023
- Total value
- $3.12M
- +$2.26M (+262.4%) vs. Q3 2023
- New holders
- 4
- 1 more added
- Sold out
- 14
- 12 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VVOS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 22 | $242.7K |
| Q1 2026 | 25 | $2.15M |
| Q4 2025 | 20 | $1.34M |
| Q3 2025 | 23 | $2.13M |
| Q2 2025 | 19 | $1.27M |
| Q1 2025 | 21 | $1.00M |
| Q4 2024 | 20 | $2.00M |
| Q3 2024 | 23 | $630.7K |
| Q2 2024 | 19 | $433.8K |
| Q1 2024 | 16 | $647.4K |
| Q4 2023 | 18 | $3.12M |
| Q3 2023 | 28 | $860.6K |
| Q2 2023 | 31 | $2.39M |
| Q1 2023 | 30 | $1.71M |
| Q4 2022 | 27 | $629.7K |
| Q3 2022 | 30 | $1.38M |
| Q2 2022 | 28 | $2.82M |
| Q1 2022 | 28 | $6.66M |
| Q4 2021 | 29 | $5.17M |
| Q3 2021 | 37 | $9.14M |
| Q2 2021 | 29 | $11.7M |
| Q1 2021 | 18 | $5.45M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Vivos Therapeutics, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Strategic Wealth Designers | 128,789 | $1.60M | 0.24% | −3,090,916−96.0% | Reduced |
| Armistice Capital, LLC | 57,000 | $709.1K | 0.02% | +57,000 | New |
| Schonfeld Strategic Advisors LLC | 50,100 | $623.2K | 0.01% | +50,100 | New |
| Vanguard Group Inc | 10,579 | $131.6K | 0.00% | −604,436−98.3% | Reduced |
| Tower Research Capital LLC (TRC) | 1,718 | $21.4K | 0.00% | +1,718 | New |
| Newbridge Financial Services Group, Inc. | 1,295 | $16.1K | 0.01% | +1,295 | New |
| Signaturefd, LLC | 547 | $6.80K | 0.00% | −13,124−96.0% | Reduced |
| Group One Trading, L.P. | 388 | $4.83K | 0.00% | +175+82.2% | Added |
| Ronald Blue Trust, Inc. | 4,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 67 | $833 | 0.00% | −1,600−96.0% | Reduced |
| BlackRock Inc. | 42 | $522 | 0.00% | −995−95.9% | Reduced |
| Kozak & Associates, Inc. | 49 | $351 | 0.00% | −1,156−95.9% | Reduced |
| Credit Agricole S A | 2,365 | $294 | 0.00% | −56,738−96.0% | Reduced |
| Global Retirement Partners, LLC | 23 | $165 | 0.00% | −547−96.0% | Reduced |
| Steward Partners Investment Advisory, LLC | 8 | $100 | 0.00% | −192−96.0% | Reduced |
| Wells Fargo & Company | 7 | $87 | 0.00% | −150−95.5% | Reduced |
| Cutler Group LP | 12 | $0 | 0.00% | −6,088−99.8% | Reduced |
| Royal Bank of Canada | 7 | $0 | 0.00% | −432−98.4% | Reduced |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −201,941−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −87,697−100.0% | Sold out |
| Wealth Enhancement Advisory Services, LLC | 0 | $0 | 0.00% | −53,334−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −45,650−100.0% | Sold out |
| Apexium Financial, LP | 0 | $0 | 0.00% | −40,667−100.0% | Sold out |
| LPL Financial LLC | 0 | $0 | 0.00% | −35,484−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −29,655−100.0% | Sold out |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −18,653−100.0% | Sold out |
| Perkins Capital Management Inc | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Lincoln National Corp | 0 | $0 | 0.00% | −14,817−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −9,257−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −26−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −167−100.0% | Sold out |